The Christie NHS Foundation Trust
- Country
- ๐ฌ๐งUnited Kingdom
- Ownership
- -
- Established
- 2007-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.christie.nhs.uk/
TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment
- Conditions
- Metastatic Melanoma
- Interventions
- First Posted Date
- 2013-11-26
- Last Posted Date
- 2023-04-20
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 2
- Registration Number
- NCT01995344
- Locations
- ๐ฌ๐ง
The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom
MRI in Pre-operative Radiotherapy for Soft Tissue Sarcoma: MISTS Study
- Conditions
- Sarcoma
- First Posted Date
- 2013-10-08
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 15
- Registration Number
- NCT01956019
- Locations
- ๐ฌ๐ง
The Christie NHS Foundation Trust, Manchester, United Kingdom
NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)
- Conditions
- Head and Neck Squamous Cell Carcinoma
- Interventions
- Radiation: Radiotherapy
- First Posted Date
- 2013-09-25
- Last Posted Date
- 2021-10-19
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 338
- Registration Number
- NCT01950689
- Locations
- ๐ฌ๐ง
Cheltenham General Hospital, Cheltenham, Gloucestershire, United Kingdom
๐ฌ๐งClatterbridge Centre for Oncology, Bebington, Merseyside, United Kingdom
๐ฌ๐งSt James' Hospital, Leeds, West Yorkshire, United Kingdom
Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers
- Conditions
- Ampullary CancerCholangiocarcinomaBiliary Tract CancerGallbladder Cancer
- Interventions
- First Posted Date
- 2013-08-20
- Last Posted Date
- 2020-01-28
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 162
- Registration Number
- NCT01926236
- Locations
- ๐ฌ๐ง
Queen Elizabeth Hospital, Birmingham, United Kingdom
๐ฌ๐งBristol Haematology & Oncology Centre, Bristol, United Kingdom
๐ฌ๐งNorth Cumbria University Hospitals, Carlisle, United Kingdom
Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy
- Conditions
- SarcomaLymphoma
- First Posted Date
- 2013-08-14
- Last Posted Date
- 2015-02-04
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 50
- Registration Number
- NCT01921998
- Locations
- ๐ฌ๐ง
The Christie NHS Foundation Trust, Manchester, United Kingdom
The Use of Rectal Balloons in Radical Pelvic Radiotherapy - a Feasibility Study
- Conditions
- Prostate Cancer
- First Posted Date
- 2013-04-30
- Last Posted Date
- 2014-07-30
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 10
- Registration Number
- NCT01842750
- Locations
- ๐ฌ๐ง
Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
A Phase I Study of CD19 Specific T Cells in CD19 Positive Malignancy
- Conditions
- CD19 Positive Non-Hodgkin Lymphoma
- First Posted Date
- 2011-12-16
- Last Posted Date
- 2023-04-19
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 17
- Registration Number
- NCT01493453
- Locations
- ๐ฌ๐ง
The Christie NHS Foundation Trust, Manchester, United Kingdom
Phase II Study of Fractionated 90Y Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy as an Initial Therapy of Follicular Lymphoma
- Conditions
- Follicular Lymphoma
- Interventions
- First Posted Date
- 2011-12-16
- Last Posted Date
- 2019-10-15
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 76
- Registration Number
- NCT01493479
- Locations
- ๐ซ๐ท
Centre Hospitalier Universitaire de Lille, Lille, France
๐ซ๐ทCentre Hospitalier Universitaire de Nantes, Nantes, France
๐ซ๐ทCentre Henri Becquerel, Rouen, France
Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus
- Conditions
- Carcinoma of the Oesophagus
- Interventions
- Radiation: Radical external beam radiotherapy, 50Gy in 25 fractions
- First Posted Date
- 2011-10-27
- Last Posted Date
- 2013-08-19
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 36
- Registration Number
- NCT01460888
- Locations
- ๐ฌ๐ง
The Christie NHS Foundation Trust, Manchester, United Kingdom
๐ฌ๐งSouthampton General Hospital, Southampton, United Kingdom
Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy
- Conditions
- Bladder Cancer
- First Posted Date
- 2011-04-27
- Last Posted Date
- 2021-08-13
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 50
- Registration Number
- NCT01343121
- Locations
- ๐ฌ๐ง
The Christie NHS Foundation Trust, Manchester, Gtr Manchester, United Kingdom